Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease
- PMID: 2208797
- PMCID: PMC1535179
- DOI: 10.1111/j.1365-2249.1990.tb05406.x
Plasma and tissue interleukin-2 receptor levels in inflammatory bowel disease
Abstract
Plasma and tissue interleukin-2 receptor (IL-2R) levels were determined in patients with active ulcerative colitis and Crohn's disease. Compared with healthy controls (median 440 U/ml; range 240-900), significantly higher levels of plasma IL-2R were present in patients with active ulcerative colitis (median 1180 U/ml; range 580-7150; P less than 0.002) and Crohn's disease (median 1340 U/ml; range 480-9000; P less than 0.002). Compared with other laboratory parameters, plasma IL-2R levels were related most closely to clinical score of disease activity in Crohn's disease. Plasma IL-2R levels also reflected the clinical course and may provide a more accurate assessment of disease activity in Crohn's disease. In plasma of patients undergoing intestinal resection of active inflammatory bowel disease, raised levels of IL-2R were present in samples from mesenteric vein (draining inflamed intestine) compared with those from peripheral vein. In tissue homogenates of colonic biopsies, significantly higher levels of IL-2R were present in specimens from colons with active ulcerative colitis compared with healthy controls (median 230.2, range 20.7-581.5 versus 77.9, range 34.2-291.3; P less than 0.02).
Similar articles
-
Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease.J Pediatr Gastroenterol Nutr. 1996 Aug;23(2):164-71. doi: 10.1097/00005176-199608000-00012. J Pediatr Gastroenterol Nutr. 1996. PMID: 8856584 Clinical Trial.
-
Increased concentrations of interleukin 1 beta, interleukin-2, and soluble interleukin-2 receptors in endoscopical mucosal biopsy specimens with active inflammatory bowel disease.Gut. 1992 Jan;33(1):55-8. doi: 10.1136/gut.33.1.55. Gut. 1992. PMID: 1740278 Free PMC article.
-
High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis.Gut. 1991 Dec;32(12):1531-4. doi: 10.1136/gut.32.12.1531. Gut. 1991. PMID: 1773961 Free PMC article.
-
T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells.Gastroenterology. 1990 Mar;98(3):639-46. Gastroenterology. 1990. PMID: 2298368
-
Soluble interleukin-2 receptor as a marker of lymphocyte activation in childhood Crohn's disease.J Pediatr Gastroenterol Nutr. 1991 Oct;13(3):277-84. doi: 10.1097/00005176-199110000-00007. J Pediatr Gastroenterol Nutr. 1991. PMID: 1791504
Cited by
-
Adequacy of mucosal biopsies for evaluation of intestinal cytokine-specific mRNA. Comparative study of RT-PCR in biopsies and isolated cells from normal and inflamed intestine.Dig Dis Sci. 1995 Jul;40(7):1498-505. doi: 10.1007/BF02285198. Dig Dis Sci. 1995. PMID: 7543040
-
Common variable immunodeficiency with CD4+ T lymphocytopenia and overproduction of soluble IL-2 receptor associated with Turner's syndrome and dorsal kyphoscoliosis.J Clin Pathol. 1997 Oct;50(10):876-9. doi: 10.1136/jcp.50.10.876. J Clin Pathol. 1997. PMID: 9462277 Free PMC article.
-
Soluble interleukin-2 receptors in ulcerative colitis.Mediators Inflamm. 1993;2(2):115-8. doi: 10.1155/S096293519300016X. Mediators Inflamm. 1993. PMID: 18475512 Free PMC article.
-
Blood levels of pro-inflammatory and anti-inflammatory cytokines during an oral glucose tolerance test in patients with symptoms suggesting reactive hypoglycemia.Braz J Med Biol Res. 2016 Jul 11;49(8):e5195. doi: 10.1590/1414-431X20165195. Braz J Med Biol Res. 2016. PMID: 27409331 Free PMC article.
-
Therapeutic interventions in gastrointestinal disease based on an understanding of inflammatory mediators.Agents Actions. 1992;Spec No:C22-6. doi: 10.1007/BF01996091. Agents Actions. 1992. PMID: 1359743 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical